| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 30 May 2024 | 23 May 2024 |
| INDRAYANI BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 inter alia to consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31 2024 along with audit report of Statutory auditors and other business matters. Approved the audited financial results along with audited report for the quarter and year ended 31 March 2024. (As Per BSE Announcement Dated on 31.05.2024) Please find attached updates. (As Per BSE Announcement dated on 01.07.2024) | ||
| Board Meeting | 10 Feb 2024 | 4 Feb 2024 |
| INDRAYANI BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2024 inter alia to consider and approve INDRAYANI BIOTECH LIMITED has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2024 inter alia to consider and approve the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter & nine months ended December 31 2023 along with the Limited Review Report of Statutory Auditor and any other business with the permission of the Chair. Pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015, the Board of Directors at their meeting held on today, i.e., 10-02-2024 has approved the unaudited financial results for the quarter and nine months ended December 31, 2023. Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, the Board of Directors at their meeting held today, i.e., 10-02-2024, has approved the appointment of V.Santhanakrishnan as a Company Secretary in Dindigul Farm Product Limited, a material subsidiary of the Company and necessary disclosure is provided as annexure. (As Per BSE Announcement dated on 10.02.2024) | ||
| Board Meeting | 10 Jan 2024 | 6 Jan 2024 |
| INDRAYANI BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/01/2024 inter alia to consider and approve To consider the proposal for increasing the authorized share capital subject to the shareholders approval. To consider and approve the conversion of unsecured loans into equity under Section 62(3) of the Companies Act 2013 subject to the shareholders approval. Any other business with the permission of the Chair. INDRAYANI BIOTECH LTD. has informed BSE about Board Meeting to be held on 10 Jan 2024 to consider Increase in authorised capital / Other business. The Board of Directors of the Company, at their meeting held on today, January 10, 2024, have inter-alia considered and approved the following matters: Recommendations to get approval from shareholders of the Company through postal ballot for the below mentioned items: To consider and to grant approval to increase authorised share capital To consider and to grant approval to amend the Articles of Association of the Company To consider and approve an amendment in the terms and conditions of existing unsecured loan arrangements availed from Mr. Kasiraman Sayee Sundar, Managing Director & M/s. Bougainvillea Investments Private Limited Took note of the resignation of Mr. Rajesh Kumar Sundarray (ACS membership number: A66744) as Company Secretary & Compliance Officer with effect from closing hours on January 10, 2024 and has appointed Mr. V Santhanakrishnan (ACS membership number: A54146) for the position of Company Secretary & Compliance Officer with effect from January 11, 2024. Pursuant to Regulation 30 of SEBI LODR, the Board of Directors of the Company, at their meeting held today, January 10, 2024, have inter-alia considered the following: Recommendations to get the approval from the shareholders of the Company through postal ballot for the following Increase of authorised share capital from Rs.46 crores to Rs.65 crores and consequential amendment to the capital clause of the memorandum of association of the Company Amendment in the Articles of association of the Company Summary of the proposed amendments in Memorandum and Articles of association of the Company are provided in the annexure. The Board of Directors at their meeting held today, January 10, 2024, has took note of the Resignation of Mr.Rajesh Kumar Sundarray (ICSI Membership no.A66744), from the office of the Company Secretary and Compliance officer with effect from closing hours of January 10, 2024. The Board of Directors at their meeting held today, January 10, 2024, has appointed Mr.V.Santhanakrishnan (ICSI Membership no.A54146), for the position of Company Secretary and Compliance officer with effect from January 11, 2024. (As Per BSE Announcement Dated on 10/01/2024) Disclosure pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (As Per BSE Announcement Dated on 11/01/2024) | ||
| Board Meeting | 14 Nov 2023 | 8 Nov 2023 |
| INDRAYANI BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2023 inter alia to consider and approve the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter & half year ended September 30 2023 along with the Limited Review Report of Statutory Auditor and any other business with the permission of the Chair. Board of Directors in its meeting held today i.e., on Tuesday, November 14, 2023, the Directors have inter-alia, approved the Unaudited Financial Results (Standalone and Consolidated) along with the Limited Review Report for the quarter & half year ended September 30, 2023. Pursuant to Regulation 33 of SEBI (LODR) Regulations 2015, the Board of directors in its Meeting held on today i.e. 14/11/2023 has approve the unaudited financial results for the quarter and half year ended on September 30, 2023. (As Per BSE Announcement Dated on 14/11/2023) | ||
| Board Meeting | 1 Nov 2023 | 27 Oct 2023 |
| INDRAYANI BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/11/2023 inter alia to consider and approve To recommend Payment of dividend on 12% Compulsorily Convertible Preference Shares. To consider and approve the allotment of Equity shares by conversion of Compulsorily Convertible Preference Shares subject to lock in period of 6 months. To consider and approve the conversion of Warrants into Equity Shares subject to lock in period of 6 months. Any other matter with the permission of the chair. | ||
| Board Meeting | 29 Aug 2023 | 29 Aug 2023 |
| Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose the Outcome of the Board Meeting held on August 29, 2023. | ||
| Board Meeting | 11 Aug 2023 | 5 Aug 2023 |
| INDRAYANI BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2023 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results along with limited review by the Statutory Auditors of the Company for the quarter ended June 30 2023 We wish to inform that at the meeting of Board of Directors held today i.e., on Friday, August 11, 2023, the Directors have inter-alia, approved the following: 1. Approved the Unaudited Financial Results (Standalone and Consolidated) with the Limited Review Report for the quarter ended June 30, 2023 (Q1) pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 2. Re-appointment of Mr. Krishnamurthi Ravichandran, Practicing Company Secretary as the Secretarial Auditor of the company for the Financial Year 2023-24. 3. Appointment of Mr. Kanumuru Rajesh as an Internal Auditor of the Company for the Financial Year 2023-24. Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, we wish to inform you that the Board of Directors of the company at the board meeting held on Friday, August 11, 2023 has re-appointed Mr. Krishnamurthi Ravichandran, Practicing Company Secretary as the Secretarial Auditor of the company for the FY 2023-23 and appointed Mr. Kanumuru Rajesh as an Internal Auditor of the company for the FY 2023-24. (As Per BSE Announcement dated on 11.08.2023) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
